Role of CD247 in Salt-Sensitive Hypertension and Renal Disease

CD247 在盐敏感性高血压和肾脏疾病中的作用

基本信息

  • 批准号:
    8508937
  • 负责人:
  • 金额:
    $ 32.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2017-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Experimental and human data indicate that infiltration of immune cells into the kidney is important in the development of hypertension and kidney disease. Preliminary data in this proposal indicate that infiltrating T cells in the kidney are activated, that they can serve as a source of elevated cytokines and AngII, and that adoptive transfer of the activated, infiltrating cells harvested from the kidney of diseased Dahl SS rats ca mediate disease in donor animals. Moreover, preliminary data from unique animal models developed for this application in which recombination activating gene 1 (Rag1) or CD247, two important genes in immune cell signaling have been genetically mutated in the Dahl SS genetic background, supports the concept that infiltrating T cells in the kidney can mediate hypertension and renal disease. Of particular note, genetic association studies indicate that CD247 is important in hypertension and kidney disease in humans. This unique translational aspect of the proposal emphasizes the important link between the experimental observations made in animals in this proposal and human disease. These novel data demonstrate the importance of infiltrating immune cells in the kidney in the development of salt-sensitive hypertension and renal damage. It is not known, however, what immune cell type(s) is/are important in the response or what factors mediate the hypertension and renal damage. We propose that the infiltrating cells, specifically T lymphocytes, exert deleterious actions by releasing vasoactive factors (cytokines and/or AngII) in the kidney to exaggerate the ongoing disease process. Experiments in this proposal will test the general hypothesis that CD247, a gene associated with human hypertension, affects hypertension and renal disease by altering T lymphocyte infiltration and activation in the kidney. As a corollary to this hypothesis, we propose that the infiltrating immune cells act by increasing intrarenal cytokines and AngII which affect kidney function. This hypothesis will be tested in three mechanistically-based, Specific Aims. Aim 1 will test the hypothesis that CD247 mediates infiltration of T cells into the kidney in Dahl SS rats. Aim 2 will test the hypothesis that infiltrating T cells produce proinflammatory cytokines (i.e. IL-6) and AngII in the kidney during salt-sensitive hypertension and kidney damage in Dahl SS rats. Aim 3 will test the hypothesis that intrarenal IL-6 and AngII participate in the development of salt-sensitive hypertension and renal damage in the Dahl SS rat by altering renal function. These integrative aims will address this hypothesis using a comprehensive approach ranging from cellular and molecular mechanisms to whole animal physiology and pathophysiology and utilize animal models specifically developed for this proposal.
描述(由申请人提供):实验和人体数据表明,免疫细胞对肾脏的渗透在高血压和肾脏疾病的发展中是重要的。这项研究的初步数据表明,肾脏中浸润性T细胞被激活,它们可以作为升高的细胞因子和血管紧张素Ⅱ的来源,过继转移从患病的Dahl SS大鼠的肾脏中获得的活化的浸润性细胞可能会在供体动物中介导疾病。此外,在Dahl SS的遗传背景下,重组激活基因1(Rag1)或CD247是免疫细胞信号转导中的两个重要基因,为这一应用开发的独特动物模型的初步数据支持了肾脏中T细胞渗入可介导高血压和肾脏疾病的概念。特别值得注意的是,遗传关联研究表明,CD247在人类高血压和肾脏疾病中起着重要作用。该提案的这一独特的翻译方面强调了该提案中对动物进行的实验观察与人类疾病之间的重要联系。这些新的数据表明,肾脏中免疫细胞的渗透在盐敏感型高血压和肾脏损害的发展中的重要性。然而,目前尚不清楚什么免疫细胞类型(S)在这一反应中起重要作用,也不知道什么因素介导了高血压和肾脏损害。我们认为,浸润性细胞,特别是T淋巴细胞,通过在肾脏中释放血管活性因子(细胞因子和/或血管紧张素Ⅱ)来发挥有害作用,从而夸大正在进行的疾病过程。这项提议中的实验将检验与人类高血压相关的基因CD247通过改变肾脏中T淋巴细胞的渗透和激活来影响高血压和肾脏疾病的普遍假设。作为这一假说的推论,我们认为浸润性免疫细胞通过增加肾内细胞因子和血管紧张素转换酶来影响肾功能。这一假设将在三个以机械为基础的具体目标中得到检验。目的1验证CD247介导T细胞进入Dahl SS大鼠肾脏的假说。目的2验证Dahl SS大鼠盐敏感型高血压和肾损害过程中,肾脏中T细胞分泌促炎细胞因子(即IL-6)和血管紧张素转换酶(AngII)的假说。目的验证肾内IL-6和AngII通过改变肾功能参与Dahl SS大鼠盐敏感型高血压和肾损害的假说。这些综合目标将使用从细胞和分子机制到整个动物生理学和病理生理学的综合方法来解决这一假说,并利用专门为这一提议开发的动物模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David L. Mattson其他文献

EGF Deficiency in the Renal Cortex Contributes to Salt-Sensitive Hypertension via Upregulation of ENaC Activity
  • DOI:
    10.1016/j.bpj.2011.11.3543
  • 发表时间:
    2012-01-31
  • 期刊:
  • 影响因子:
  • 作者:
    Tengis S. Pavlov;Vladislav Levchenko;Paul M. O’Connor;Andrey Sorokin;David L. Mattson;Julian H. Lombard;Allen W. Cowley;Alexander Staruschenko
  • 通讯作者:
    Alexander Staruschenko
T Cell Immunometabolism and Redox Signaling in Hypertension
  • DOI:
    10.1007/s11906-021-01162-5
  • 发表时间:
    2021-12-01
  • 期刊:
  • 影响因子:
    5.100
  • 作者:
    David L. Mattson;Justine M. Abais-Battad
  • 通讯作者:
    Justine M. Abais-Battad
Functional Genomics
  • DOI:
    10.1007/978-94-010-0448-0
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David L. Mattson
  • 通讯作者:
    David L. Mattson
From GWAS to functional genomics-based precision medicine
从全基因组关联研究到基于功能基因组学的精准医学
  • DOI:
    10.1038/nrneph.2017.21
  • 发表时间:
    2017-03-06
  • 期刊:
  • 影响因子:
    39.800
  • 作者:
    David L. Mattson;Mingyu Liang
  • 通讯作者:
    Mingyu Liang
An integrated genetic analysis of disease
疾病的综合遗传分析
  • DOI:
    10.1038/nrneph.2018.26
  • 发表时间:
    2018-04-09
  • 期刊:
  • 影响因子:
    39.800
  • 作者:
    David L. Mattson
  • 通讯作者:
    David L. Mattson

David L. Mattson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David L. Mattson', 18)}}的其他基金

Gut Metabolites, T cells, and Salt-Sensitive Hypertension
肠道代谢物、T 细胞和盐敏感性高血压
  • 批准号:
    10568068
  • 财政年份:
    2023
  • 资助金额:
    $ 32.11万
  • 项目类别:
CD14 and Salt-Sensitive Hypertension
CD14 和盐敏感性高血压
  • 批准号:
    10633269
  • 财政年份:
    2022
  • 资助金额:
    $ 32.11万
  • 项目类别:
CD14 and Salt-Sensitive Hypertension
CD14 和盐敏感性高血压
  • 批准号:
    10522446
  • 财政年份:
    2022
  • 资助金额:
    $ 32.11万
  • 项目类别:
Role of CD247 in Salt-Sensitive Hypertension and Renal Disease
CD247 在盐敏感性高血压和肾脏疾病中的作用
  • 批准号:
    8396503
  • 财政年份:
    2012
  • 资助金额:
    $ 32.11万
  • 项目类别:
Role of CD247 in Salt-Sensitive Hypertension and Renal Disease
CD247 在盐敏感性高血压和肾脏疾病中的作用
  • 批准号:
    8730147
  • 财政年份:
    2012
  • 资助金额:
    $ 32.11万
  • 项目类别:
Renal Infiltration of Immune Cells Mediates Hypertension
免疫细胞的肾浸润介导高血压
  • 批准号:
    8230994
  • 财政年份:
    2011
  • 资助金额:
    $ 32.11万
  • 项目类别:
Renal Infiltration of Immune Cells Mediates Hypertension
免疫细胞的肾浸润介导高血压
  • 批准号:
    7389280
  • 财政年份:
    2008
  • 资助金额:
    $ 32.11万
  • 项目类别:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
精氨酸摄取机制调节肾脉管系统中的一氧化氮
  • 批准号:
    7502047
  • 财政年份:
    2003
  • 资助金额:
    $ 32.11万
  • 项目类别:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
精氨酸摄取机制调节肾脉管系统中的一氧化氮
  • 批准号:
    7671452
  • 财政年份:
    2003
  • 资助金额:
    $ 32.11万
  • 项目类别:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
精氨酸摄取机制调节肾脉管系统中的一氧化氮
  • 批准号:
    8136966
  • 财政年份:
    2003
  • 资助金额:
    $ 32.11万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 32.11万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 32.11万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 32.11万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 32.11万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 32.11万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 32.11万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 32.11万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 32.11万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 32.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了